|
期刊名称：JOURNAL OF LOWER GENITAL TRACT DISEASE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Journal of Lower Genital Tract Disease (JLGTD) is a must-have resource for any professional committed to the study, prevention, diagnosis, and management of cervical cancer and other lower genital tract diseases and disorders. Through a mix of original research, reviews, case reports, meeting abstracts, and more, JLGTD helps you:
- Recognize, evaluate, and treat diseases of the cervix, vulva, and vagina
- Recommend tailored management to women with HPV infections
- Achieve greater expertise in performing colposcopic examinations
JLGTD publishes practice guidelines from the American Society for Colposcopy and Cervical Pathology (ASCCP) that address a host of clinically relevant topics, including HPV vaccination. This journal is a key resource for enhancing your professional insight and clinical skills, and staying updated on a rapidly changing area of medicine.
Publication & Editorial Staff Contacts
Publisher
Nancy Axelrod
nancy.axelrod@wolterskluwer.com
Production Editor
Lisa Cleary
lisa.cleary@wolterskluwer.com
Senior Production Associate
Lisa Folden
lisa.folden@wolterskluwer.com
Marketing Manager
Robert O’Malley
robert.omalley@wolterskluwer.com
LWW Business Offices
530 Walnut Street
Philadelphia, PA 19106
Phone: 215-521-8300
www.lww.com
|
Editor-in-Chief
Dr. Edward J. Wilkinson
Department of Pathology and Laboratory Medicine
University of Florida College of Medicine
1600 S.W. Archer Road
Gainesville, FL 32610
Executive Editor
Dr. Thomas M. Julian
Department of Ob/Gyn
University of Wisconsin
Clinical Science Ctr, H4/648
600 Highland Avenue
Madison, WI 53792
Society Offices
American Society for Colposcopy and Cervical Pathology
152 West Washington Street
Hagerstown, MD 21740
Phone: 301-733-3640
Phone: 800-787-7227 (toll-free)
Fax: 301-733-5775
| |
|
Instructions to Authors
For basic science articles, we encourage submission on laboratory investigations, in vitro and ex vivo models, animal models, and pilot data in humans. The range of topics of interest is very broad and may include human papillomavirus biology, genital tract physiology, bioactivity of a new agent for prevention or treatment of lower genital tract disease, epidemiology, and other basic research issues.
Manuscript Requirements. Manuscripts submitted to the Journal of Lower Genital Tract Disease must conform to the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," established by the International Committee of Medical Journal Editors (JAMA 1993;269:2282–6) (1).
Manuscript Submission. Submit all manuscripts online through the Journal of Lower Genital Tract Disease Editorial Web site (http://jlgtd.edmgr.com).
First-time users: Please click the Register button from the main menu and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, re-registration is unnecessary, even if your status changes (that is, author, reviewer, or editor).
Authors: Please click the login button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact Sandy Smith, Managing Editor (sfsmith@wisc.edu).
General Manuscript Format. All manuscripts must be submitted in English. The manuscript must include (in the following order): title page, précis, abstract, body of the text, acknowledgments, references, figures, legends, and tables. Manuscripts should be approximately 1,000 to 4,000 words (about 4–16 manuscript pages), dependent upon the type of report.
Title page. The title page should include in order (1) the title; (2) the running title, a short version of the title (40 characters or less); (3) authors' names as they wish them to appear with the first name/initial, middle name/initial, and last name of each author, in that order, followed by each author's highest academic degree(s); (4) institutional affiliation, city, state, and country (when other than United States) in which the study was carried out; (5) source(s) of financial support [disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s)]; (6) disclaimers (when needed); (7) name, address, business and home telephone numbers, fax number, and e-mail address of the corresponding author; and (8) name and address of the author to whom reprints should be sent (when different from the corresponding author).
For manuscripts with two or more authors, each must have participated actively and sufficiently in the study design, performance, critical analysis, and reporting. The inclusion of an author should be based only on substantial contribution. Each author must have final approval of the submitted manuscript. Individuals contributing to the manuscript in lesser roles (including participants in collaborative trials) may be mentioned in an acknowledgment. Acknowledgment should not be given for clerical or purely editing assistance.
Précis. The précis appears after the title page and with the title in the Journal's table of contents. It should be a single sentence, limited to 25 words or less, describing the major conclusion of the work.
Abstract Page with Key Words/Phrases. On the next page, a structured abstract of 250 words or less should accompany full-length articles. The structured abstract should contain 4 paragraphs with the following headings: (1) Objective, stating the hypothesis of the study; (2) Materials and Methods, including the means for problem solving, the subjects (number and relevant characteristics), the intervention studied, and a brief statistical analysis; (3) Results, including the outcome of the study and statistical significance; and (4) Conclusions, stating the outcome importance. Abstracts are not necessary for editorials, commentaries, correspondence, home study courses, opinion pieces, book reviews, and abstracts from meetings.
Key Words. Key words should appear immediately beneath the abstract and consist of 3 to 5 words or terms used for indexing. We recommend using the terms from the medical subject headings of Index Medicus (2).
Text. Write manuscripts in the active voice. Express ideas briefly, clearly, and concisely. Take the time to condense your manuscript and express it confidently in simple, declarative sentences. Write simply and naturally, the way you speak. Do not make statements that your report or references do not unsubstantiate (3).
Use only standard abbreviations (4). Spell out all abbreviations in full preceding their first usage in the text.
Verify reports claiming to be the "first of a kind" with the source(s) of the literature searched, the years included in the search, and key words searched. Enclose direct quotations with quotation marks and attribute in full the author and source, including the exact page numbers. Reference closely paraphrased material within the text, to leave no doubt to the source of the original information.
For drugs, devices, or patented procedures, state the generic or common name, followed in parentheses by the trade name (optional), city, and country of manufacture.
For randomized controlled trials, specifically state the method for randomization. When human and nonhuman investigation/experimentation has taken place, manuscripts must state that the appropriate institutional review body granted approval before the study was begun.
Reports on nonhuman subjects must state that institutional approval of the project was obtained before the study began, and that institutional guidelines for the care of these subjects were followed. State the type of nonhuman subjects in the title, abstract, key words, and materials and methods section of the report.
Statistical analyses should specify the tests used and to which portions of the data they were applied rather than simply list the tests. If using statistical computer program, identify the program.
References. List references cited in the manuscript as a separate section immediately following the text. Authors must verify all references. Follow the citation style of the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (1), and use journal abbreviations recognized by Index Medicus (2).
Number references sequentially in the order cited in the text. Number references cited only in a figure or table according to their first mention in the text. Do not use personal communications or materials "submitted" or "in preparation" as references. Materials accepted for publication but not yet published may be cited followed by "(in press)”.
References with 7 or more authors should list only the first 6, followed by "et al." The following examples are given to demonstrate correct style:
Journal: Surname and initials of author(s), title of article, name of journal, year, volume number, first and last page.
Scholz H, Kurtz A. Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney. J Clin Invest 1993;91:1088–94.
Books: Surname and initials of author(s), title and subtitle, edition (other than first), city, publisher, year, volume (where applicable), first and last page cited.
Kurman RJ, Solomon D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York: Springer-Verlag; 1994:18–29.
Book chapter: Surname and initials of author(s), title of article, chapter number (if present), title of book, editor, edition (other than first), city, publisher, year, volume (where applicable), first and last page.
Weidner N, Buckalew VM. Sickle cell anemia, sickle cell trait, and polycythemic states. In: Tisher CC, Brenner BM, eds. Renal Pathology (vol. 2). Philadelphia: JB Lippincott Company; 1989:1417–46.
Abstract: Surname and initials of author(s), title of abstract, "abstract" in parentheses, name of journal, year volume number, page.
Flower RJ. The mediators of steroid action (abstract). Nature 1986;320:20.
Supplement: Surname and initials of author(s), title of article, name of journal, year, volume number, supplement number in parentheses, first and last page.
Kamm DE, Genin M. Diuretic-induced azotemia. Kidney Int 1983;24(suppl 16):S58–S60.
Figures: Digital art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated postscript) file. Electronic photographs (radiographs, CT scans, etc) and scanned images must have a resolution of at least 300 dpi. Line art must have a resolution of at least 1200 dpi (dots per inch). If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. If you do not have the capability to create CMYK files, please disregard this step. Indicate in your cover letter that you are unable to produce CMYK files. Cite figures consecutively in the text, and number them in the order in which they are discussed. Detailed Figure Instructions: For a step by step guide for submitting Digital Art to please visit www.LWWonline.com. Click “For Authors” then click “Artwork” in the menu to the right. Visit the “Digital Art Checklist” and “5 Steps for Creating Digital Artwork” for specific guidelines.
Tables. Up to five tables will be printed without charge to the author(s). Label tables consecutively, using Arabic numerals, and follow the references pages. Follow the table number with a title for the table. Head a table exceeding 1 page with the table number followed by "continued" in parentheses and the table heading. Submit tables containing special symbols or artwork as camera-ready copy.
Illustrations. Number all illustrations sequentially with Arabic numerals, in the order cited in text. On a separate page, label legends by figure number and briefly describe the illustration.
Color Illustrations. Color figures will be printed in black and white unless special arrangements are made with the editor or the authors wish to pay at a rate of approximately $650 for the first figure.
Line Drawings. Line drawings may be submitted when of professional quality.
Photographic Prints. Patient identity must be protected, or written permission from the patient must accompany the print. Letters, arrows, and markings must be of professional quality.
Figures. Figures reproduced from another publication require accompanying written permissions from the author(s) of the work and the holder of the copyright to the work. Include credits detailing the authorship and source of the materials in the legend.
Supplemental Digital Content
Supplemental Digital Content (SDC): Authors may submit SDC via Editorial Manager to LWW journals that enhance their article's text to be considered for online posting. SDC may include standard media such as text documents, graphs, audio, video, etc. On the Attach Files page of the submission process, please select Supplemental Audio, Video, or Data for your uploaded file as the Submission Item. If an article with SDC is accepted, our production staff will create a URL with the SDC file. The URL will be placed in the call-out within the article. SDC files are not copy-edited by LWW staff, they will be presented digitally as submitted. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.
SDC Call-outs
Supplemental Digital Content must be cited consecutively in the text of the submitted manuscript. Citations should include the type of material submitted (Audio, Figure, Table, etc.), be clearly labeled as "Supplemental Digital Content," include the sequential list number, and provide a description of the supplemental content. All descriptive text should be included in the call-out as it will not appear elsewhere in the article.
Example:
We performed many tests on the degrees of flexibility in the elbow (see Video, Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our results inconclusive.
List of Supplemental Digital Content
A listing of Supplemental Digital Content must be submitted at the end of the manuscript file. Include the SDC number and file type of the Supplemental Digital Content. This text will be removed by our production staff and not be published.
Example:
Supplemental Digital Content 1. wmv
SDC File Requirements
All acceptable file types are permissible up to 10 MBs. For audio or video files greater than 10 MBs, authors should first query the journal office for approval. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.
AFTER ACCEPTANCE
Authors must submit an electronic version of the final accepted manuscript. Electronic files should be submitted in a standard word processing format; Microsoft Word (or Corel WordPerfect) is preferred. Although conversions can be made from other word processing formats, the vagaries of the conversion process may introduce errors. Do not submit ASCII text files. Do not use automatic numbering or footnotes for references. The Journal does not assume responsibility for errors in the conversion of customized software, newly released software, and special characters. Authors preparing manuscripts on Macintosh computers should not use the Fast Save option.
Electronic page proofs and corrections
Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. The corresponding author will receive portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) via e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected pages to the publisher.
The author is responsible to ensure that there are no errors in the proofs. Authors who are not native English speakers are strongly encouraged to have their manuscript carefully edited by a native English-speaking colleague. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Electronic proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints
Authors will receive a reprint order form including prices when their manuscript is processed. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201; Fax: 410.528.4434; E-mail: reprints@lww.com with any questions.
Copying. Authorization to photocopy material from the Journal for any purpose must be granted in writing by Lippincott Williams & Wilkins for the American Society for Colposcopy and Cervical Pathology.
Copyright Statement. The American Society for Colposcopy and Cervical Pathology Copyright holds the copyright on all published articles. All authors must sign a copyright transfer agreement and submit it with the final revised manuscript.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements. A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Checklist. The corresponding author should complete the checklist for journal submission and forward it with the manuscript.
Duplicate Publication. If a report, including abstracts, by any of the named authors has been previously published in any medium dealing in any respect with the same data, in part or in full, as that reported in the submitted manuscript, a reprint of that report must be submitted with the manuscript under consideration.
The corresponding author should inform the Executive Editor of the similarities and differences of the reports. This requirement specifically includes reports in which a few different patients, animal, laboratory experiments or data have been added to an existing publication.
Conflict of Interest. Authors must inform the Executive Editor in a letter accompanying the manuscript of any commercial or other association that might present conflict of interest, such as ownership, financial holdings, equity interests, consultant activity, patent-licensing, or emotional interests that might influence the report. This information will be confidential and known only to the editor. If the manuscript is accepted, the editor will decide how to best make the information known. Listing sources of financial and institutional support does not necessarily imply a conflict of interest.
Disclaimer. Statements and opinions expressed in the manuscript are those of the author(s) and not necessarily those of the editor(s) or publisher. The editor(s) or publisher disclaims any responsibility or liability for such information. The author(s), editor(s), and publisher do not guarantee, warrant, or endorse any product or service advertised in the publication, nor do they guarantee any claim made by the manufacturer of said product or service. Please make every effort to comply with the previously stated requirements. Failure to do so may delay review and subsequent publication in the Journal.
Consent. For research involving human subjects, both the cover letter and the body of the manuscript must state that the research was evaluated and approved or exempted from review by the relevant institutional review body. In addition, both must state that written informed consent was obtained from all research participants.
Patients should not be identifiable from information provided. This includes both written descriptions and photographic depictions. Authors are responsible for ensuring compliance with relevant privacy regulations and for obtaining release for confidential information.
Authors should disclose in their cover letter all financial relationships they may have either with a company whose product might be affected by the research described or with any company that makes or markets a competing product. At the editor's discretion, this information may be disclosed at the time of publication.
References
1. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. http://www.icmje.org.
2. National Library of Medicine. List of journals indexed in Index Medicus. Washington, DC: US Government Printing Office (published annually). Available at http://www.nlm.nih.gov/tsd/serials/lji.html.
3. Roman K, Raphaelson J. Writing that Works. 3rd ed. New York: Harper Resource; 2000.
4. Style Manual Committee, Council of Biology Editors. Scientific style and format: the CBE manual for authors, editors, and publishers. 6th ed. Cambridge: Cambridge University Press; 1994.
Author’s Manuscript Checklist
__ Manuscript with title page, abstract, references double spaced, and figure legends if applicable
__ Include on the title page: title; authors’ names with major degrees; institutional affiliations; source of funding, including NIH, Wellcome Trust, Howard Hughes Medical Institute (HHMI); short title; and the corresponding author’s name, address, telephone numbers (office and home), and fax number.
__ Précis of 25 words or less
__ A structured abstract of 250 words or less
__ Key words/phrases (3 to 5 words) should follow the structured abstract.
__ Materials and Methods section includes statements describing selection of randomization of subjects, institutional review of the study, treatment of nonhuman subjects, and statistical methods in relation to areas studied.
__ Randomized controlled trials should specifically state the method for randomization. When human and nonhuman investigation/experimentation has taken place, manuscripts and their cover letters must state that the appropriate institutional review body granted approval before the study was begun.
— Reports on nonhuman subjects must state that institutional approval of the project was obtained before the study began, and that institutional guidelines for the care of these subjects were followed. The type of nonhuman subjects must be stated in the title, abstract, key words, and Materials and Methods section of the report.
__ References in proper format and cited in numbered order as they appear in the text.
__ Figures, illustrations, photographs, or other artwork saved as TIFF, EPS, or PowerPoint files
__ Authorship statement, financial disclosures, conflict of interest, author’s agreement form, copyright transfer, and permission statements accompany the manuscript.
Editorial Board
| Editor-in-Chief |
|
Edward J. Wilkinson, MD
Department of Pathology and Laboratory Medicine
University of Florida College of Medicine
1600 S.W. Archer Road
Gainesville, FL 32610 |
|
Executive Editor |
|
Thomas M. Julian, MD
Department of Obstetrics and Gynecology
University of Wisconsin
Clinical Science Center, H4/648
600 Highland Avenue
Madison, WI 53792 |
|
Editor, Home Study Course |
Mark Spitzer, MD
Department of Obstetrics and Gynecology
New York Methodist Hospital
506 Sixth Street
Brooklyn, NY 11215 |
Senior Associate Editors |
Daron G. Ferris, MD
Augusta, GA |
L. Stewart Massad, MD
Springfield, IL |
Associate Editors |
J. Thomas Cox, MD
Santa Barbara, CA
Hope K. Haefner, MD
Ann Arbor, MI
Kenneth D. Hatch, MD
Tucson, AZ
Howard W. Jones III, MD
Nashville, TN |
Kenneth L. Noller, MD
Boston, MA
Mark H. Schiffman, MD, MPH
Rockville, MD
Leo B. Twiggs, MD
Miami, FL |
Editorial Board |
David Allen, CGO
Victoria, Australia
Barbara S. Apgar, MD, MS
Ann Arbor, MI
J.L. Benedet, MD
Vancouver, British Columbia, Canada
Christine Bergeron, MD
Cedex, France
Jacob Bornstein, MD
Haifa, Israel
Louis Burke, MD
Boston, MA
John W. Calkins, MD
Kansas City, KS
Monserrat Cararach, MD
Barcelona, Spain
Philip E. Castle, PhD, MPH
Rockville, MD
Terence Colgan, MD
Toronto, Ontario, Canada
Christopher Crum, MD
Boston, MA
Teresa M. Darragh, MD
San Francisco, CA
Diane Davey, MD
Lexington, KY
Gordon Davis, MD
Phoenix, AZ
Prof. Giuseppe De Palo
Milan, Italy
Santiago Dexeus, MD
Barcelona, Spain
Charles J. Dunton, MD
Philadelphia, PA
Annabelle Farnsworth, FRCPA, FIAC
North Ryde, Australia
Prof. Henry Kitchener
Manchester, United Kingdom
Burton A. Krumholz, MD
Roslyn Heights, NY
Gordon Lickrish, MD
Toronto, Ontario, Canada
|
Neal M. Lonky, MD, MPH
Anaheim, CA
David Luesley, MD
Birmingham, United Kingdom
Dennis M. O'Connor
Louisville, KY
Anthony W. Opipari, MD, PhD
Ann Arbor, MI
Walter Prendiville, MD
Dublin, Ireland
Luis M. Puig-Tintore, MD
Barcelona, Spain
Michel Roy, MD
Quebec, PQ, Canada
Mary Rubin, RNC, PhD, CRNP
Sausalito, CA
R. Michael Shier, MD
Toronto, Ontario, Canada
Albert Singer, MD
London, United Kingdom
Mark Spitzer, MD
Brooklyn, NY
Adolf Stafl, MD, PhD
Waukesha, WI (Emeritus)
Silvio Tatti, MD
Buenos Aires, Argentina
Roberto Testa, MD
Buenos Aires, Argentina
Aureli Torñe, MD
Barcelona, Spain
Jose E. Torres, MD
New Orleans, LA (Emeritus)
Duane E. Townsend, MD
Park City, UT
Patrick Walker, MD
London, United Kingdom
Alan G. Waxman, MD
Albuquerque, NM
Claudia L. Werner, MD
Dallas, TX
George D. Wilbanks Jr, MD
Tampa, FL
|
|
|
|
|
